Attenuation of neutrophil-mediated myocardial ischemia-reperfusion injury by a calpain inhibitor
- 1 April 2002
- journal article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 282 (4) , H1421-H1426
- https://doi.org/10.1152/ajpheart.00626.2001
Abstract
Calpains are ubiquitous neutral cysteine proteases. Although their physiological role has yet to be clarified, calpains seem to be involved in the expression of cell adhesion molecules. Therefore, we hypothesized that a selective calpain inhibitor could attenuate polymorphonuclear (PMN) leukocyte-induced myocardial ischemia-reperfusion (I/R) injury. We examined the effects of the calpain inhibitor Z-Leu-Leu-CHO in isolated ischemic (20 min) and reperfused (45 min) rat hearts perfused with PMNs. Z-Leu-Leu-CHO (10 and 20 μM, respectively) significantly improved left ventricular developed pressure (LVDP) ( P < 0.01) and the maximal rate of development of LVDP ( P < 0.01) compared with I/R hearts perfused without Z-Leu-Leu-CHO. In addition, Z-Leu-Leu-CHO significantly reduced PMN adherence to the vascular endothelium and subsequent infiltration into the postischemic myocardium ( P < 0.01). Moreover, Z-Leu-Leu-CHO significantly inhibited expression of P-selectin on the rat coronary microvascular endothelium ( P < 0.01). These results provide evidence that Z-Leu-Leu-CHO significantly attenuates PMN-mediated I/R injury in the isolated perfused rat heart to a significant extent via downregulation of P-selectin expression.Keywords
This publication has 48 references indexed in Scilit:
- Transcriptional and translational regulation of calpain in the rat heart after myocardial infarction – effects of AT1 and AT2 receptor antagonists and ACE inhibitorBritish Journal of Pharmacology, 2001
- Recombinant soluble P-selectin glycoprotein ligand-1 protects against myocardial ischemic reperfusion injury in catsCardiovascular Research, 1999
- Effects of a Metalloproteinase that Truncates P-selectin Glycoprotein Ligand on Neutrophil-induced Cardiac Dysfunction in Ischemia/ReperfusionJournal of Molecular and Cellular Cardiology, 1998
- Six-Hour Window of Opportunity for Calpain Inhibition in Focal Cerebral Ischemia in RatsStroke, 1998
- The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusionCardiovascular Research, 1996
- Calpain is Implicated in Rat Myocardial Injury after Ischemia or ReperfusionJapanese Circulation Journal, 1994
- Protective Effect of the Protease Inhibitor Leupeptin Against Myocardial StunningJournal of Cardiovascular Pharmacology, 1993
- Contribution of Calcium-activated Neutral Protease to the Degradation Process of Ischemic Heart.Japanese Circulation Journal, 1991
- Calcium-activated neutral protease inhibitor(E-64c) and reperfusion for experimental myocardial infarction.Japanese Heart Journal, 1989
- Reduction of experimentally produced acute myocardial infarction size by a new synthetic inhibitor, NCO-700, against calcium-activated neutral protease.Japanese Heart Journal, 1982